Results of Second-Look Laparotomy in Advanced Stage Epithelial Ovarian Cancer and Factors Influencing the Results

被引:0
|
作者
Kose, Faruk Mehmet [1 ]
Turan, Taner [1 ]
Boran, Nurettin [1 ]
Karacay, Ozlem [1 ]
Tulunay, Gokhan [1 ]
Koc, Sevgi [1 ]
Aykan, Burcu [1 ]
机构
[1] Etlik Obstet & Gynecol Training & Res Hosp, Oncol Dept, Ankara, Turkey
关键词
ovarian cancer; second-look laparotomy; prognostic factor;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The aim of the study was to determine the results of second-look laparotomy (SLL) in patients with stage III C and IV epithelial ovarian cancer and factors influencing the results. Materials and Methods: Medical records of seventy-five patients who underwent SLL between January 1998 and March 2003 were reviewed. The outcome of the SLL procedure and recurrence rates in SLL negative patients were evaluated. The effect of patient age, tumor stage, grade, size, and histological type, presence of ascites, volume of ascites, peritoneal cytology and type of chemotherapy on SLL results were also evaluated. Results: The mean age of the patients was 52 years and mean duration of follow-up was 39 months. In this study, fifty patients received paclitaxel/platinum (six courses) and twenty-five patients received epirubicin/paclitaxel/platinum (six courses) chemotherapy. Of these 75 patients, 47 (62.7%) were SLL negative, 15 (20%) had microscopic residual disease and 13 (17.3%) had gross macroscopic disease. Recurrence occurred in 20 (42.6%) of 47 SLL negative patients. The mean time to recurrence was 14.5 months. The volume of ascites correlated positively with the probability of finding residual tumor at SLL (p<0.05). Patient age, clinical stage, histological type and grade, tumor size, presence of ascites and result of peritoneal cytology were found not to influence the outcome of SLL. Discussion: It is difficult to determine the factors influencing the outcome of SLL because of the insadequacy of the procedure. It is generally considered that SLL doesn't contribute to survival but only gives information about the state of the disease.
引用
收藏
页码:302 / 305
页数:4
相关论文
共 50 条
  • [41] The role of factor XIII in surgery for advanced stage of epithelial ovarian cancer
    Yazdian, Mahtab
    Groeben, Harald
    Ataseven, Beyhan
    Schneider, Stephanie
    Baert, Thais
    Bommert, Mareike
    Traut, Alexander
    Elfers-Wassenhoven, Alexandra
    Bruess, Ulrich
    Schwameis, Richard
    du Bois, Andreas
    Wagner, Uwe
    Harter, Philipp
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 305 (05) : 1311 - 1318
  • [42] LONG-TERM RESULTS OF CYCLOPHOSPHAMIDE, ADRIAMYCIN AND PLATINUM CHEMOTHERAPY IN ADVANCED EPITHELIAL OVARIAN-CANCER
    HARDING, M
    MILSTED, R
    HOLE, D
    CORDINER, J
    BARR, W
    SOUKOP, M
    KENNEDY, J
    SOUTTER, WP
    KAYE, S
    ANNALS OF ONCOLOGY, 1991, 2 (03) : 231 - 233
  • [43] SURVIVAL WITH INTRAPERITONEAL CISPLATIN IN ADVANCED OVARIAN-CANCER AFTER 2ND-LOOK LAPAROTOMY
    DEGRAMONT, A
    DEMUYNCK, B
    LOUVET, C
    GONZALEZCANALI, G
    VARETTE, C
    PIGNE, A
    MARPEAU, L
    HERBULOT, P
    LAGADEC, B
    CADY, J
    SOUBRANE, D
    COUTURIER, JY
    DELFAU, S
    SEZEUR, A
    GALLOT, D
    MALAFOSSE, M
    BARRAT, J
    KRULIK, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (01): : 7 - 11
  • [44] Evaluation of non-invasive diagnostic tests for the second look in epithelial ovarian cancer
    Enguidanos, AG
    Azanza, EC
    Recasens, JD
    Samper, FL
    Herrero, JAJ
    Abbad, RSD
    REVISTA CLINICA ESPANOLA, 1998, 198 (08): : 502 - 505
  • [45] Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association Consortium
    Babic, Ana
    Harris, Holly R.
    Vitonis, Allison F.
    Titus, Linda J.
    Jordan, Susan J.
    Webb, Penelope M.
    Risch, Harvey A.
    Rossing, Mary Anne
    Doherty, Jennifer A.
    Wicklund, Kristine
    Goodman, Marc T.
    Modugno, Francesmary
    Moysich, Kirsten B.
    Ness, Roberta B.
    Kjaer, Susanne K.
    Schildkraut, Joellen
    Berchuck, Andrew
    Pearce, Celeste L.
    Wu, Anna H.
    Cramer, Daniel W.
    Terry, Kathryn L.
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (03) : 460 - 469
  • [46] Intraperitoneal (IP) port cytology after completion of primary therapy for advanced stage ovarian cancer: A novel approach to a "second look"
    Grette, Katherine
    Long, Beverly
    Finan, Michael A.
    Rocconi, Rodney P.
    GYNECOLOGIC ONCOLOGY, 2019, 154 (02) : 290 - 293
  • [47] Results of interval debulking surgery in advanced stage ovarian cancer:: an exposed-non-exposed study
    Morice, P
    Brehier-Ollive, D
    Rey, A
    Atallah, D
    Lhommé, C
    Pautier, P
    Pomel, C
    Camatte, S
    ANNALS OF ONCOLOGY, 2003, 14 (01) : 74 - 77
  • [48] Trends in therapy and survival of advanced stage epithelial ovarian cancer patients in the Netherlands
    van Altena, Anne M.
    Karim-Kos, Henrike E.
    de Vries, Esther
    Kruitwagen, Roy F. P. M.
    Massuger, Leon F. A. G.
    Kiemeney, Lambertus A.
    GYNECOLOGIC ONCOLOGY, 2012, 125 (03) : 649 - 654
  • [49] hMSH2 and GTBP expression in advanced stage epithelial ovarian cancer
    A Ercoli
    G Ferrandina
    G Raspaglio
    M Marone
    N Maggiano
    P Del Mastro
    P Benedetti Panici
    S Mancuso
    G Scambia
    British Journal of Cancer, 1999, 80 : 1665 - 1671
  • [50] Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer
    Aletti, Giovanni D.
    Dowdy, Sean
    Podratz, Karl C.
    Cliby, William A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (06) : 1862 - 1868